tiprankstipranks
Advertisement
Advertisement

CTMX Stock Latest News

CytomX Therapeutics Adds Dr. Fuchs to Board
Company AnnouncementsCytomX Therapeutics Adds Dr. Fuchs to Board
4d ago
8K
CTMX
Citizens healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Citizens healthcare analysts hold an analyst/industry conference call
23d ago
CTMX
EXEL
CytomX Shareholders Approve Expanded Equity and Capital Plans
PremiumCompany Announcements
CytomX Shareholders Approve Expanded Equity and Capital Plans
1M ago
8K
CTMX
3 Best Cheap Stocks Under $10 to Buy Now, According to Analysts
PremiumMarket News
3 Best Cheap Stocks Under $10 to Buy Now, According to Analysts
2M ago
DC
CWH
CytomX Expands High-Value Bispecific Cancer Partnership With Regeneron
PremiumCompany Announcements
CytomX Expands High-Value Bispecific Cancer Partnership With Regeneron
2M ago
8K
CTMX
CytomX Therapeutics expands licensing agreement with Regeneron
PremiumThe FlyCytomX Therapeutics expands licensing agreement with Regeneron
2M ago
CTMX
REGN
5 Healthcare Stocks Set to Join the Russell 3000
Premium
Market News
5 Healthcare Stocks Set to Join the Russell 3000
2M ago
QSI
AGEN
CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts
Premium
Weekend Updates
CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts
2M ago
AMT
CTMX
CytomX Earnings Call: Varseta‑M Drives Long Runway
PremiumCompany Announcements
CytomX Earnings Call: Varseta‑M Drives Long Runway
2M ago
CTMX
CytomX Therapeutics initiated with an Outperform at Wolfe Research
PremiumThe Fly
CytomX Therapeutics initiated with an Outperform at Wolfe Research
2M ago
CTMX
CytomX’s CX-801 Enters Key Early Cancer Trial Phase, Putting CTMX Back on Investor Radar
PremiumCompany Announcements
CytomX’s CX-801 Enters Key Early Cancer Trial Phase, Putting CTMX Back on Investor Radar
3M ago
CTMX
CytomX Therapeutics price target lowered to $11 from $17 at H.C. Wainwright
PremiumThe Fly
CytomX Therapeutics price target lowered to $11 from $17 at H.C. Wainwright
3M ago
CTMX
CytomX Therapeutics: Early-Stage Pipeline, Trial Setbacks and High Risks on the Road to Profitability
PremiumCompany AnnouncementsCytomX Therapeutics: Early-Stage Pipeline, Trial Setbacks and High Risks on the Road to Profitability
3M ago
CTMX
CytomX Earnings Call Highlights Varseta-M Momentum
Premium
Company Announcements
CytomX Earnings Call Highlights Varseta-M Momentum
3M ago
CTMX
CytomX Therapeutics reports Q1 EPS (10c), consensus (11c)
Premium
The Fly
CytomX Therapeutics reports Q1 EPS (10c), consensus (11c)
3M ago
CTMX
CytomX Therapeutics participates in a conference call with JPMorgan
PremiumThe Fly
CytomX Therapeutics participates in a conference call with JPMorgan
4M ago
CTMX
CytomX Therapeutics Signals Progress in Varseta-M Trial
PremiumCompany Announcements
CytomX Therapeutics Signals Progress in Varseta-M Trial
4M ago
CTMX
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts
4M ago
COYA
CTMX
CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler
PremiumThe Fly
CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler
4M ago
CTMX
CytomX Therapeutics Raises $234 Million in Equity Offering
PremiumCompany AnnouncementsCytomX Therapeutics Raises $234 Million in Equity Offering
4M ago
8K
CTMX
CytomX Therapeutics price target raised to $16 from $10 at Barclays
Premium
The Fly
CytomX Therapeutics price target raised to $16 from $10 at Barclays
4M ago
CTMX
CytomX Therapeutics price target raised to $16 from $8 at Jefferies
Premium
The Fly
CytomX Therapeutics price target raised to $16 from $8 at Jefferies
4M ago
CTMX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >